SS Innovations International (SSII) Enterprise Value Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -274.77% |
| Dec 31, 2025 | -221.71% |
| Sep 30, 2025 | -183.42% |
| Jun 30, 2025 | -304.34% |
| Mar 31, 2025 | -297.34% |
| Dec 31, 2024 | -149.54% |
| Sep 30, 2024 | -204.27% |
| Jun 30, 2024 | -38.29% |
| Mar 31, 2024 | -174.72% |
| Dec 31, 2023 | -252.71% |
| Sep 30, 2023 | -2,468.47% |
| Jun 30, 2023 | -341.58% |
| Mar 31, 2023 | -253.90% |
| Dec 31, 2022 | -112.86% |
| Sep 30, 2022 | -157.92% |
| Jun 30, 2022 | -88.32% |
| Mar 31, 2022 | -77.98% |
| Dec 31, 2021 | -124.81% |
| Sep 30, 2021 | -27.00% |
| Jun 30, 2021 | -17.07% |
| Mar 31, 2021 | -0.23% |
| Dec 31, 2020 | 29.19% |
| Sep 30, 2020 | 89.04% |
| Jun 30, 2020 | 65.29% |
| Mar 31, 2020 | 65.91% |
| Dec 31, 2019 | 51.41% |
| Sep 30, 2019 | 53.00% |
| Jun 30, 2019 | 52.73% |